COE/RANKINGS/Career ladder and resp

Discussion in 'AstraZeneca' started by anonymous, Jan 14, 2019 at 7:04 AM.

Tags: Add Tags
?

Agree? Disagree?

  1. Agree?

    0 vote(s)
    0.0%
  2. Disagree?

    0 vote(s)
    0.0%
  1. anonymous

    anonymous Guest

    Did anyone who was a symbicort bevespi daliresp rep actually male COE from last year. I’d like to know the ratio of Symbicort farxiga reps versus symbicort bevespi/Dali reps who made COE, received higher rankings all year and received career ladder promotions. I believe the rankings system to be completely flawed from last year, giving the symbicort farxiga reps a very unfair advantage in receiving higher performance and as such greater reward than their counterparts?
     
  2. anonymous

    anonymous Guest

    Newsflash..... Coe rankings have always been unfair and completely flawed. Nothing more than luck of the draw. There’s been years where reps carrying same products in the same geographies have seen one rep win coe and other one doesn’t just due to product ‘direction’. Corporate couldn’t care less that it’s flawed all it is a guaranteed yearly vacation for upper leadership.
     
  3. anonymous

    anonymous Guest

    It is truly a flawed system. We should only be compared against other reps carrying the EXACT same portfolio. Not reps carrying a different product mix. Check it out on the COE page. They have always gone against their own guidance and it is just not fair.
     
  4. anonymous

    anonymous Guest


    Totally agreed ! It is ridiculous and unfair. We are calling on the same people , so why should they get paid more for doing the same job? Even though they changed it this year , it is still not a fair way to promote. It does not promote teamwork at all . 50/50 this year when the real diabetes team is 70% on farxiga ??? It will be interesting to see the COE rankings for that team with so much invested in diabetes.
     
  5. anonymous

    anonymous Guest

    Coe hasn’t been announced yet.....
     
  6. anonymous

    anonymous Guest

    How in the hell do they know who generated a script when multiple people are promoting the same drug to the same customer and 90% of all recorded calls are fake?
     
  7. anonymous

    anonymous Guest

    wonder when
     
  8. anonymous

    anonymous Guest

    Having been in the HO for many years before I retired, I can tell you more than 1 person got a good laugh about the accuracy of rep sales data. Also, the COE was also a running joke about how those people were selected. There is no actual way to tell which rep is responsible for the business. You see, the only that really matters is what we ship out of the warehouse to our customers. If you accidentally get credit for it or not, it doesn’t really matter to the company. I can tell you it’s this way for all of the pharma people I know with many pharma companies. We also knew that reps only work a few hours a day, so we figured you came out even on the sales end with inaccurate data.

    It’s been years since I have posted on CP. I have always assumed you guys were a lot more savvy about how things actually worked. Hopefully, this make things a little clearer for you.
     
  9. anonymous

    anonymous Guest

    same time as as it always is. march or so after all the guesstimating of data is cooked
     
  10. anonymous

    anonymous Guest

    So many respiratory reps who are very upset with the situation regarding rankings last year and the unfair advantage The Symbicort:farxiga reps got over the Symbicort/Bevespi/Daliresp reps. Wouldn’t be surprised if eventually there is a lawsuit against AZ. In general AZ is going to lose most of their really talented hard working (or actually working) reps as there are other opportunities out there that don’t make it impossible to receive appropriate recognition and be rewarded and have career advancement.